Michael Klockow

1.1k total citations · 1 hit paper
18 papers, 928 citations indexed

About

Michael Klockow is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Michael Klockow has authored 18 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Organic Chemistry. Recurrent topics in Michael Klockow's work include Ion channel regulation and function (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Phosphodiesterase function and regulation (4 papers). Michael Klockow is often cited by papers focused on Ion channel regulation and function (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Phosphodiesterase function and regulation (4 papers). Michael Klockow collaborates with scholars based in Germany, United States and Canada. Michael Klockow's co-authors include N. Hennrich, Hermann Lang, Hans Orth, Harald Metz, Inge Lues, Guenther Haeusler, Norbert Beier, Edward G. Lakatta, M. C. Capogrossi and Giovanni Gambassi and has published in prestigious journals such as Circulation Research, FEBS Letters and European Journal of Biochemistry.

In The Last Decade

Michael Klockow

18 papers receiving 873 citations

Hit Papers

Proteinase K from Tritirachium album Limber 1974 2026 1991 2008 1974 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Klockow Germany 12 544 211 116 108 91 18 928
J.R.C. Muniz Brazil 19 774 1.4× 84 0.4× 79 0.7× 46 0.4× 47 0.5× 40 1.1k
Florent Guillain France 26 1.4k 2.6× 331 1.6× 39 0.3× 40 0.4× 78 0.9× 47 1.8k
Rolf Furter Switzerland 22 995 1.8× 50 0.2× 45 0.4× 94 0.9× 143 1.6× 32 1.2k
Michael Zeece United States 25 706 1.3× 99 0.5× 197 1.7× 18 0.2× 20 0.2× 50 1.8k
Christian Birr Germany 17 730 1.3× 53 0.3× 22 0.2× 258 2.4× 31 0.3× 58 1.1k
Harald Metz Germany 8 417 0.8× 19 0.1× 112 1.0× 47 0.4× 73 0.8× 10 733
Masaki Kojima Japan 18 537 1.0× 26 0.1× 123 1.1× 40 0.4× 112 1.2× 66 1.0k
Karine Berthelot France 20 967 1.8× 29 0.1× 51 0.4× 81 0.8× 24 0.3× 31 1.2k
Taiji Inui Japan 16 472 0.9× 82 0.4× 64 0.6× 269 2.5× 22 0.2× 47 864

Countries citing papers authored by Michael Klockow

Since Specialization
Citations

This map shows the geographic impact of Michael Klockow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Klockow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Klockow more than expected).

Fields of papers citing papers by Michael Klockow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Klockow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Klockow. The network helps show where Michael Klockow may publish in the future.

Co-authorship network of co-authors of Michael Klockow

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Klockow. A scholar is included among the top collaborators of Michael Klockow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Klockow. Michael Klockow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ravens, Ursula, Q. Li, Herbert M. Himmel, et al.. (1997). Stereoselectivity of actions of the calcium sensitizer [+]-EMD 60263 and its enantiomer [-]-EMD 60264. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(6). 733–742. 12 indexed citations
2.
Klockow, Michael, et al.. (1994). Stereoselectivity of the positive inotropic effects of newer diazinone-cardiotonics. Bioorganic & Medicinal Chemistry Letters. 4(21). 2585–2588. 7 indexed citations
3.
Lues, Inge, et al.. (1993). The Two Mechanisms of Action of Racemic Cardiotonic EMD 53998, Calcium Sensitization and Phosphodiesterase Inhibition, Reside in Different Enantiomers. Journal of Cardiovascular Pharmacology. 21(6). 883–892. 71 indexed citations
4.
Klockow, Michael, et al.. (1993). Synthesis and biological activities of meribendan and related heterocyclic benzimidazolo-pyridazinones. European Journal of Medicinal Chemistry. 28(2). 129–140. 53 indexed citations
5.
Gambassi, Giovanni, M. C. Capogrossi, Michael Klockow, & Edward G. Lakatta. (1993). Enantiomeric dissection of the effects of the inotropic agent, EMD 53998, in single cardiac myocytes. American Journal of Physiology-Heart and Circulatory Physiology. 264(3). H728–H738. 30 indexed citations
6.
Miller, Rachel, H. Wolf, N. F. Beier, et al.. (1992). Novel diazinone derivatives separate myofilament Ca2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium.. Circulation Research. 70(6). 1081–1090. 31 indexed citations
7.
Klockow, Michael, et al.. (1992). Preparation of the enantiomers of the novel CA-sensitizer EMD 53 998. Bioorganic & Medicinal Chemistry Letters. 2(6). 589–592. 13 indexed citations
8.
Klockow, Michael. (1991). Ca2+-sensitization or increase in Ca2+-transient as cardiotonic principles shown in cardiac myocytes. Journal of Molecular and Cellular Cardiology. 23. S29–S29. 2 indexed citations
9.
Beier, Norbert, et al.. (1991). The Novel Cardiotonic Agent EMD 53 998 is a Potent “Calcium Sensitizer”. Journal of Cardiovascular Pharmacology. 18(1). 17–27. 54 indexed citations
10.
Honerjäger, P, et al.. (1989). Imidazopyridines. Journal of Cardiovascular Pharmacology. 13(5). 673–681. 10 indexed citations
11.
Klockow, Michael, et al.. (1986). Studies on the receptor profile of bisoprolol.. PubMed. 36(2). 197–200. 14 indexed citations
12.
Haeusler, G., P. Schelling, K Becker, et al.. (1985). High β1-Selectivity and Favourable Pharmacokinetics as the Outstanding Properties of Bisoprolol. Journal of Cardiovascular Pharmacology. 8. S2–S15. 33 indexed citations
13.
Hennrich, N., et al.. (1974). Proteinase K from Tritirachium album Limber. European Journal of Biochemistry. 47(1). 91–97. 535 indexed citations breakdown →
14.
Hennrich, N., et al.. (1973). Aminopeptidase K fromTritirachium albumLimber. I. Isolation and Some Properties. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 354(2). 1339–1346. 9 indexed citations
15.
Klockow, Michael & N. Hennrich. (1972). Determination of reactive groups of polymer carriers with amino acid 4‐nitroanilides. FEBS Letters. 26(1-2). 53–55. 5 indexed citations
16.
Hennrich, N., et al.. (1972). Preparation and Properties of Carrier-Bound Enzymes. European Journal of Biochemistry. 25(1). 129–135. 35 indexed citations
17.
Hennrich, N., Michael Klockow, Hermann Lang, & W.O. Berndt. (1969). Isolation and properties of bromelin protease. FEBS Letters. 2(5). 278–280. 11 indexed citations
18.
Machleidt, Hans, et al.. (1963). Organische Fluorverbindungen, III. Eine einfache Synthese von Brom‐fluor‐essigsäureäthylester. Justus Liebig s Annalen der Chemie. 667(1). 47–50. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026